| Aim: This research has evaluated the extract’s antifungal
effects on Candida glabrata and Candida krusei in a laboratory
environment.
Materials and methods: In this research, to evaluate the
antifungal effect and the minimal inhibitory concentration (MIC)
determination of chicory extract, the Clinical and Laboratory
Standards Institute (CLSI) was used. Candida glabrata and C.
krusei funguses were procured from the Tehran Pasteur Institute;
they were grown in the relative growing environment according
to the required conditions. Also for further assurance about the
macrodilution method reality, the agar well diffusion method
was used. Finally, the obtained results were analyzed using the
Statistical Package for the Social Sciences version 16 software.
Results: The MIC for the chicory extract was 50 µg/mL for C.
krusei and 100 µg/mL for C. glabrata. On the contrary, in the
evaluation of different concentrations of the chicory extract by
the agar well diffusion method, C. krusei’s lack of growth in
similar concentrations was greater than that of C. glabrata. As
a result, the findings related to both the methods of agar well
diffusion and MIC prevention concentration maximization proved
that C. krusei sensitivity to the chicory extract is more compared
with the sensitivity of C. glabrata.
Conclusion: Chicory extract has the benefits of low price,
accessibility, and proper taste as compared with nystatin. It
also has fewer side effects, and after a clinical test, it could be
considered a proper candidate as an antifungal drug against
infections caused by C. krusei and C. glabrata.
Clinical significance: The results obtained from this research
have shown that chicory extract has antifungal features and is
the best choice as an antifungal drug because of its low price,
accessibility, and proper taste as compared with nystatin. |